Frank X Leonard Novo Cure LTD (NVCR) insider trading activity

Frank X Leonard is EVP, Pres., Novocure Oncology of NovoCure Ltd. Currently has a direct ownership of 198,648 shares of NVCR, which is worth approximately $3.66 Million. The most recent transaction as insider was on Sep 15, 2022, when has been sold 12,271 shares (Ordinary Shares) at a price of $88.65 per share, resulting in proceeds of $1,087,824. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 199K

23.2% 3M change

24.08% 12M change

Total Value Held $3.66 Million

Frank X Leonard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 15 2022	SELL Open market or private sale	$1,087,824 $88.65 p/Share	12,271 Reduced 14.8%	70,642 Ordinary Shares
Sep 15 2022	BUY Exercise of conversion of derivative security	$39,447 $7.15 p/Share	5,517 Added 6.24%	82,913 Ordinary Shares
Sep 09 2022	SELL Open market or private sale	$163,944 $88.0 p/Share	1,863 Reduced 2.17%	84,150 Ordinary Shares
Sep 06 2022	SELL Open market or private sale	$108,741 $78.57 p/Share	1,384 Reduced 1.58%	86,013 Ordinary Shares
Sep 02 2022	SELL Open market or private sale	$46,159 $79.04 p/Share	584 Reduced 0.66%	87,397 Ordinary Shares
Sep 01 2022	SELL Open market or private sale	$1,100,435 $77.43 p/Share	14,212 Reduced 13.91%	87,981 Ordinary Shares
Aug 02 2022	SELL Open market or private sale	$28,839 $69.66 p/Share	414 Reduced 0.4%	102,193 Ordinary Shares
Jul 05 2022	BUY Grant, award, or other acquisition	$18,433 $59.08 p/Share	312 Added 0.3%	102,607 Ordinary Shares
Mar 08 2022	SELL Open market or private sale	$52,154 $70.1 p/Share	744 Reduced 0.72%	102,295 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$39,078 $70.41 p/Share	555 Reduced 0.54%	103,039 Ordinary Shares
Mar 03 2022	SELL Open market or private sale	$69,285 $74.5 p/Share	930 Reduced 0.89%	103,594 Ordinary Shares
Mar 03 2022	BUY Grant, award, or other acquisition	-	17,371 Added 14.25%	104,524 Ordinary Shares
Sep 02 2021	SELL Open market or private sale	$74,644 $138.23 p/Share	540 Reduced 0.62%	87,153 Ordinary Shares
Aug 03 2021	SELL Open market or private sale	$49,013 $149.43 p/Share	328 Reduced 0.37%	89,158 Ordinary Shares
Aug 02 2021	SELL Open market or private sale	$106,508 $149.38 p/Share	713 Reduced 0.79%	89,486 Ordinary Shares
Jul 06 2021	BUY Grant, award, or other acquisition	$21,116 $137.12 p/Share	154 Added 0.17%	90,199 Ordinary Shares
Mar 08 2021	SELL Open market or private sale	$100,070 $130.81 p/Share	765 Reduced 0.84%	90,045 Restricted Share Units
Mar 04 2021	SELL Open market or private sale	$77,991 $137.55 p/Share	567 Reduced 0.62%	90,810 Restricted Share Units
Mar 02 2021	SELL Open market or private sale	$65,382 $152.05 p/Share	430 Reduced 0.52%	82,668 Restricted Share Units
Mar 02 2021	BUY Grant, award, or other acquisition	-	8,709 Added 8.7%	91,377 Restricted Share Units
Feb 27 2021	BUY Exercise of conversion of derivative security	$218,432 $149.1 p/Share	1,465 Added 1.73%	83,098 Ordinary Shares

FXL

Frank X Leonard

EVP, Pres., Novocure Oncology

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Value

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NovoCure Ltd

Track Activities on NVCR

Account